HMOs and Gut Development:​ New Clinical Evidence​

Posted: May 24,2022

Human milk oligosaccharides, or HMOs, are a group of unique and diverse oligosaccharides, representing the third largest solid compound of human milk. With the advancement of technology and research activities, more HMOs are available for infant nutrition. A new randomised, controlled, double-blind, trial shows the beneficial effect of a blend of 5 specific HMOs on gut development in full term healthy infants.

HMOs and Gut Development –​ New Clinical Evidence